Antifibrinolytic treatment in subarachnoid haemorrhage: Present state
- 1 March 1982
- journal article
- clinical trial
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 63 (1-4) , 233-244
- https://doi.org/10.1007/bf01728877
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Fibrinolytic activity of cerebral tissue after experimental subarachnoid haemorrhage: Inhibitory effect of tranexamic acid (AMCA)Acta Neurologica Scandinavica, 2009
- FIBRINOLYTIC ACTIVITY OF HUMAN BRAIN. A HISTOCHEMICAL STUDYActa Neurologica Scandinavica, 2009
- The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysmsSurgical Neurology, 1981
- Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Do antifibrinolytic agents prevent rebleeding after rupture of a cerebral aneurysm? A reviewClinical Neurology and Neurosurgery, 1980
- Tranexamic acid in subarachnoid hemorrhage. A double-blind study.Stroke, 1979
- Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA)Acta Neurochirurgica, 1979
- Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: A double‐blind clinical trialAnnals of Neurology, 1978
- Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?BMJ, 1978
- The use of antifibrinolytic substances in ruptured intracranial aneurysmsmin - Minimally Invasive Neurosurgery, 1969